VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U6101AA: VAERS reports

24 VAERS reports list lot U6101AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2019-01-18 and 2021-02-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1125%
Neurological614%
General / Systemic (non-local)614%
Musculoskeletal511%
Cardiac / Cardiovascular49%
Gastrointestinal49%
Dermatological (non-injection-site)49%
Allergic / Anaphylactic25%
Respiratory12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oregon5
Texas3
Kansas2
California2
Illinois2
North Dakota2
Arizona1
Kentucky1
North Carolina1
Utah1
Indiana1
Maryland1

Reports by month received

2019-011
2019-021
2019-041
2019-051
2019-065
2019-072
2019-091
2020-021
2020-041
2020-111
2020-125
2021-013
2021-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.